Buprenorfina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Buprenorfina" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

12doi.org

2^nd place

7^th place

4worldcat.org

5^th place

26^th place

3web.archive.org

1^st place

1drugs.com

399^th place

1,563^rd place

1books.google.com

3^rd place

14^th place

1fda.gov

447^th place

644^th place

1samhsa.gov

low place

1oup.com

485^th place

613^th place

1mayoclinicproceedings.org

low place

1medicinescomplete.com

low place

books.google.com

(EN) IUPAC, János Fischer e C. Robin Ganellin, Analogue-based Drug Discovery, John Wiley & Sons, 13 dicembre 2006, ISBN 978-3-527-60749-5. URL consultato il 10 novembre 2020.

doi.org

dx.doi.org

(EN) Michael H. Silber, Philip M. Becker e Mark J. Buchfuhrer, The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome, in Mayo Clinic Proceedings, vol. 93, n. 1, 1º gennaio 2018, pp. 59–67, DOI:10.1016/j.mayocp.2017.11.007. URL consultato l'11 aprile 2022.
Lara S. Lemon, Steve N. Caritis e Raman Venkataramanan, Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome, in Epidemiology (Cambridge, Mass.), vol. 29, n. 2, 2018-3, pp. 261-268, DOI:10.1097/EDE.0000000000000780. URL consultato il 10 novembre 2020.
Joyce Cote e Lori Montgomery, Sublingual buprenorphine as an analgesic in chronic pain: a systematic review, in Pain Medicine (Malden, Mass.), vol. 15, n. 7, 2014-07, pp. 1171-1178, DOI:10.1111/pme.12386. URL consultato il 10 novembre 2020.
Ish K Khanna e Sivaram Pillarisetti, Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain, in Journal of Pain Research, vol. 8, 4 dicembre 2015, pp. 859-870, DOI:10.2147/JPR.S85951. URL consultato il 10 novembre 2020.
Paulo Vinicius Steagall, Hélène Louise Marcelle Ruel e Tomoyo Yasuda, Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial, in BMC veterinary research, vol. 16, n. 1, 24 maggio 2020, p. 154, DOI:10.1186/s12917-020-02364-w. URL consultato l'11 novembre 2020.
T V Khroyan, J Wu e W E Polgar, BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice, in British Journal of Pharmacology, vol. 172, n. 2, 2015-1, pp. 668-680, DOI:10.1111/bph.12796. URL consultato l'11 novembre 2020.
Petra H. Wirtz, Johannes Siegrist e Anna Schuhmacher, The association between overcommitment to work and depressive symptoms is moderated by the polymorphic region of the 5-HTT gene, in Psychiatry Research, vol. 208, n. 2, 30 luglio 2013, pp. 199-200, DOI:10.1016/j.psychres.2013.01.028. URL consultato l'11 novembre 2020.
Sarah M. Brown, Michael Holtzman e Thomas Kim, Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active, in Anesthesiology, vol. 115, n. 6, 2011-12, pp. 1251-1260, DOI:10.1097/ALN.0b013e318238fea0. URL consultato l'11 novembre 2020.
David E. Moody, Wenfang B. Fang e Shen-Nan Lin, Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes, in Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 37, n. 12, 2009-12, pp. 2323-2329, DOI:10.1124/dmd.109.028605. URL consultato l'11 novembre 2020.
Sarah M. Brown, Scott D. Campbell e Amanda Crafford, P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception, in The Journal of Pharmacology and Experimental Therapeutics, vol. 343, n. 1, 2012-10, pp. 53-61, DOI:10.1124/jpet.112.193433. URL consultato l'11 novembre 2020.
R. C. Heel, R. N. Brogden e T. M. Speight, Buprenorphine: a review of its pharmacological properties and therapeutic efficacy, in Drugs, vol. 17, n. 2, 1979-02, pp. 81-110, DOI:10.2165/00003495-197917020-00001. URL consultato l'11 novembre 2020.
Nancy D. Campbell e Anne M. Lovell, The history of the development of buprenorphine as an addiction therapeutic, in Annals of the New York Academy of Sciences, vol. 1248, 2012-02, pp. 124-139, DOI:10.1111/j.1749-6632.2011.06352.x. URL consultato l'11 novembre 2020.

drugs.com

(EN) Buprenorphine, Buprenorphine Hydrochloride Monograph for Professionals, su Drugs.com. URL consultato il 10 novembre 2020.

fda.gov

(EN) FDA approves first buprenorphine implant for treatment of opioid dependence, su FDA, 24 marzo 2020. URL consultato il 10 novembre 2020.

mayoclinicproceedings.org

(EN) Michael H. Silber, Philip M. Becker e Mark J. Buchfuhrer, The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome, in Mayo Clinic Proceedings, vol. 93, n. 1, 1º gennaio 2018, pp. 59–67, DOI:10.1016/j.mayocp.2017.11.007. URL consultato l'11 aprile 2022.

medicinescomplete.com

about.medicinescomplete.com

(EN) Digital Medicines Information Suite, su MedicinesComplete. URL consultato l'11 novembre 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Joyce Cote e Lori Montgomery, Sublingual buprenorphine as an analgesic in chronic pain: a systematic review, in Pain Medicine (Malden, Mass.), vol. 15, n. 7, 2014-07, pp. 1171-1178, DOI:10.1111/pme.12386. URL consultato il 10 novembre 2020.
Paulo Vinicius Steagall, Hélène Louise Marcelle Ruel e Tomoyo Yasuda, Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial, in BMC veterinary research, vol. 16, n. 1, 24 maggio 2020, p. 154, DOI:10.1186/s12917-020-02364-w. URL consultato l'11 novembre 2020.
Petra H. Wirtz, Johannes Siegrist e Anna Schuhmacher, The association between overcommitment to work and depressive symptoms is moderated by the polymorphic region of the 5-HTT gene, in Psychiatry Research, vol. 208, n. 2, 30 luglio 2013, pp. 199-200, DOI:10.1016/j.psychres.2013.01.028. URL consultato l'11 novembre 2020.
David E. Moody, Wenfang B. Fang e Shen-Nan Lin, Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes, in Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 37, n. 12, 2009-12, pp. 2323-2329, DOI:10.1124/dmd.109.028605. URL consultato l'11 novembre 2020.
M. Aniszewska, B. Kowalik-Mikołajewska e S. Dobosz, [Hepatitis C--epidemiology, diagnosis and treatment in children], in Przeglad Epidemiologiczny, vol. 55, n. 4, 2001, pp. 503-510. URL consultato l'11 novembre 2020.
P. Huang, G. B. Kehner e A. Cowan, Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist, in The Journal of Pharmacology and Experimental Therapeutics, vol. 297, n. 2, 2001-05, pp. 688-695. URL consultato l'11 novembre 2020.
Sarah M. Brown, Scott D. Campbell e Amanda Crafford, P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception, in The Journal of Pharmacology and Experimental Therapeutics, vol. 343, n. 1, 2012-10, pp. 53-61, DOI:10.1124/jpet.112.193433. URL consultato l'11 novembre 2020.
R. C. Heel, R. N. Brogden e T. M. Speight, Buprenorphine: a review of its pharmacological properties and therapeutic efficacy, in Drugs, vol. 17, n. 2, 1979-02, pp. 81-110, DOI:10.2165/00003495-197917020-00001. URL consultato l'11 novembre 2020.
Nancy D. Campbell e Anne M. Lovell, The history of the development of buprenorphine as an addiction therapeutic, in Annals of the New York Academy of Sciences, vol. 1248, 2012-02, pp. 124-139, DOI:10.1111/j.1749-6632.2011.06352.x. URL consultato l'11 novembre 2020.

ncbi.nlm.nih.gov

Lara S. Lemon, Steve N. Caritis e Raman Venkataramanan, Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome, in Epidemiology (Cambridge, Mass.), vol. 29, n. 2, 2018-3, pp. 261-268, DOI:10.1097/EDE.0000000000000780. URL consultato il 10 novembre 2020.
Ish K Khanna e Sivaram Pillarisetti, Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain, in Journal of Pain Research, vol. 8, 4 dicembre 2015, pp. 859-870, DOI:10.2147/JPR.S85951. URL consultato il 10 novembre 2020.
T V Khroyan, J Wu e W E Polgar, BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice, in British Journal of Pharmacology, vol. 172, n. 2, 2015-1, pp. 668-680, DOI:10.1111/bph.12796. URL consultato l'11 novembre 2020.
Sarah M. Brown, Michael Holtzman e Thomas Kim, Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active, in Anesthesiology, vol. 115, n. 6, 2011-12, pp. 1251-1260, DOI:10.1097/ALN.0b013e318238fea0. URL consultato l'11 novembre 2020.

oup.com

academic.oup.com

Alison Forbes, RGN, Prabhjyot Saini e David B Rye, MD PhD, 0663 Buprenorphine/naloxone Treatment Of Refractory RLS, su academic.oup.com, Sleep, Volume 42, Issue Supplement_1, April 2019, 12 aprile 2019, pp. A264–A265. URL consultato l'11 aprile 2022.

samhsa.gov

(EN) Buprenorphine, su samhsa.gov. URL consultato il 10 novembre 2020.

web.archive.org

www.informazionisuifarmaci.it (archiviato dall'url originale il 28 dicembre 2013).
These highlights do not include all the information needed to use BUTRANS® safely and effectively. See full prescribing information for BUTRANS.BUTRANS® (buprenorphine) transdermal system CIIIInitial U.S. Approval: 1981, su app.purduepharma.com. URL consultato il 10 novembre 2020 (archiviato dall'url originale il 14 luglio 2014).
Drugs of Abuse Publication, Chapter 4, su web.archive.org, 2 novembre 2006. URL consultato il 10 novembre 2020 (archiviato dall'url originale il 2 novembre 2006).

worldcat.org

Renner, John A., Jr., 1938-, Levounis, Petros, e LaRose, Anna T., 1979-, Office-based buprenorphine treatment of opioid use disorder, Second edition, ISBN 978-1-61537-170-9, OCLC 1002302926. URL consultato il 10 novembre 2020.
Adams, H. Richard. e Papich, Mark G., Veterinary Pharmacology and Therapeutics., 9th ed, Wiley, 2013, ISBN 978-1-118-68590-7, OCLC 959873672. URL consultato l'11 novembre 2020.
Budd, Keith. e Raffa, Robert B., Buprenorphine - the unique opiod analgesic : pharmacology and clinical application, Georg Thieme, 2005, ISBN 1-58890-432-6, OCLC 63275153. URL consultato l'11 novembre 2020.
Benzon, Honorio T.,, Raja, Srinivasa, e Liu, Spencer S.,, Essentials of pain medicine, Fourth edition, ISBN 978-0-323-40196-8, OCLC 1012894215. URL consultato l'11 novembre 2020.